AURIMOD GmbH is a Vienna medical-technology company developing auricular vagus nerve stimulation for pain management. Its VIVO system delivers electrical pulses through small needle electrodes in the outer ear connected to a wearable battery-powered stimulator. The manufacturer identifies VIVO as a Class IIa medical device requiring physician prescription and application. Its VIVO Pal mobile app records patient-reported pain and wellbeing to support monitoring by patients and clinicians. Founded in 2015 as a spinout of TU Wien and the Medical University of Vienna, AURIMOD develops medical devices and conducts biomedical and clinical research on personalized neuromodulation.
Founded 2015
Team
Bernhard FabianChief Operating Officer and Authorized Signatory
